ARTICLE | Distillery Therapeutics
Neurology
March 7, 2018 7:12 PM UTC
Cell culture studies suggest inhibiting TMX2 could help treat ALS caused by hexanucleotide repeat expansions in C9orf72. In a screen of a human acute myelogenous leukemia (AML) cell line and primary m...
BCIQ Company Profiles
BCIQ Target Profiles